Literature DB >> 19811530

Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal.

Teri M Furlong1, Daniel M L Vianna, Lu Liu, Pascal Carrive.   

Abstract

Hypocretin/orexin has a well-established role in wakefulness and in the maintenance of arousal. Because stress is associated with arousal, it has been proposed that hypocretin is also involved in stress. However, it is not clear if this is true for all forms of stress. To clarify this issue, we compared four conditions combining high arousal with no or low stress (wakefulness and exploration) or high stress (contextual fear and restraint) in the rat. We looked at Fos expression in hypocretin neurons, hypocretin-1 levels in cerebrospinal fluid and cardiovascular and behavioural changes after pharmacological blockade with the dual hypocretin receptor antagonist, almorexant. Fos expression in hypocretin neurons was highest with wakefulness and exploration, also high with fear but not significant with restraint. Hypocretin-1 levels were consistent with this pattern, although the differences were not as marked. Hypocretin receptor blockade with almorexant reduced the pressor, tachycardic and locomotor responses of wakefulness and exploration as well as the pressor and sympathetic component of the tachycardic response of fear. In contrast, almorexant did not reduce the pressor and tachycardic responses of restraint and nor did it reduce the pressor, tachycardic and locomotor responses of another stressor, i.e. cold exposure. Thus, hypocretin is not involved in all forms of stress. Comparison of the different conditions suggests that, regardless of stress, hypocretin involvement occurs when the arousal associated with the response includes increased attention to environmental cues. When it does, hypocretin will at least contribute to the cardiovascular response. The findings are of clinical relevance to some forms of psychological stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811530     DOI: 10.1111/j.1460-9568.2009.06952.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  59 in total

1.  Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Authors:  Yonghui Li; Sa Li; Chuguang Wei; Huiying Wang; Nan Sui; Gilbert J Kirouac
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

2.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

Review 3.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 4.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 5.  The role of Hcrt/Orx and MCH neurons in sleep-wake state regulation.

Authors:  Barbara E Jones; Oum K Hassani
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

Review 6.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 7.  The Orexin System and Hypertension.

Authors:  Michael J Huber; Qing-Hui Chen; Zhiying Shan
Journal:  Cell Mol Neurobiol       Date:  2017-03-27       Impact factor: 5.046

8.  Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat.

Authors:  Daniele Viviani; Patrizia Haegler; Francois Jenck; Michel A Steiner
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

9.  A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects.

Authors:  Pascal Bonaventure; Sujin Yun; Philip L Johnson; Anantha Shekhar; Stephanie D Fitz; Brock T Shireman; Terry P Lebold; Diane Nepomuceno; Brian Lord; Michelle Wennerholm; Jonathan Shelton; Nicholas Carruthers; Timothy Lovenberg; Christine Dugovic
Journal:  J Pharmacol Exp Ther       Date:  2015-01-12       Impact factor: 4.030

10.  Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats.

Authors:  Aihua Li; Charles C T Hindmarch; Eugene E Nattie; Julian F R Paton
Journal:  J Physiol       Date:  2013-05-13       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.